ICD-10 Code for Disorder

The ICD-10-CM 2027 alphabetic index lists disorder with the subterms below. More specific codes depend on the details documented, as listed in the official index (1183 codes, 1053 billable).

Index entries for Disorder

acantholytic – L11.9
- specified NEC – L11.8
acute
- psychotic – see Psychosis, acute
- stress – F43.0
adjustment (grief) – F43.20
- with
  - anxiety – F43.22
    - with depressed mood – F43.23
  - conduct disturbance – F43.24
    - with emotional disturbance – F43.25
  - depressed mood – F43.21
    - with anxiety – F43.23
  - other specified symptom – F43.29
adrenal (capsule) (gland) (medullary) – E27.9
- specified NEC – E27.8
adrenogenital – E25.9 – see also Adrenogenital syndrome
- drug-induced – E25.8
- iatrogenic – E25.8
- idiopathic – E25.8
adult personality (and behavior) – F69
- specified NEC – F68.8
affective (mood) – see Disorder, mood
aggressive, unsocialized – F91.1
alcohol-related – F10.99
- with
  - amnestic disorder, persisting – F10.96
  - anxiety disorder – F10.980
  - dementia, persisting – F10.97
  - intoxication – F10.929
    - with delirium – F10.921
    - uncomplicated – F10.920
  - mood disorder – F10.94
  - other specified – F10.988
  - psychotic disorder – F10.959
    - with
      - delusions – F10.950
      - hallucinations – F10.951
  - sexual dysfunction – F10.981
  - sleep disorder – F10.982
alcohol use
- mild – F10.10
  - with
    - alcohol-induced
      - anxiety disorder – F10.180
      - bipolar and related disorder – F10.14
      - depressive disorder – F10.14
      - psychotic disorder – F10.159
      - sexual dysfunction – F10.181
      - sleep disorder – F10.182
    - alcohol intoxication – F10.129
      - delirium – F10.121
  - in remission (early) (sustained) – F10.11
- moderate or severe – F10.20
  - with
    - alcohol-induced
      - anxiety disorder – F10.280
      - bipolar and related disorder – F10.24
      - depressive disorder – F10.24
      - major neurocognitive disorder, amnestic-confabulatory type – F10.26
      - major neurocognitive disorder, nonamnestic-confabulatory type – F10.27
      - mild neurocognitive disorder – F10.288
      - psychotic disorder – F10.259
      - sexual dysfunction – F10.281
      - sleep disorder – F10.282
    - alcohol intoxication – F10.229
      - delirium – F10.221
  - in remission (early) (sustained) – F10.21
allergic – see Allergy
alveolar NEC – J84.09
amino-acid
- cystathioninuria – E72.19
- cystinosis – E72.04
- cystinuria – E72.01
- glycinuria – E72.09
- homocystinuria – E72.11
- metabolism – see Disturbance, metabolism, amino-acid
  - specified NEC – E72.89
- neonatal, transitory – P74.8
- renal transport NEC – E72.09
- transport NEC – E72.09
amnesic, amnestic
- alcohol-induced – F10.96
  - with dependence – F10.26
- due to (secondary to) – F04
- psychoactive NEC-induced – F19.96
  - with
    - abuse – F19.16
    - dependence – F19.26
- sedative, hypnotic or anxiolytic-induced – F13.96
  - with dependence – F13.26
amphetamine-type substance use
- mild – F15.10
  - in remission (early) (sustained) – F15.11
- moderate – F15.20
  - in remission (early) (sustained) – F15.21
- severe – F15.20
  - in remission (early) (sustained) – F15.21
amphetamine (or other stimulant)
- mild
  - with
    - amphetamine (or other stimulant)
      - anxiety disorder – F15.180
      - bipolar and related disorder – F15.14
      - depressive disorder – F15.14
      - obsessive-compulsive and related disorder – F15.188
      - psychotic disorder – F15.159
      - sexual dysfunction – F15.181
    - amphetamine, cocaine, or other stimulant intoxication
      - with perceptual disturbances – F15.122
      - without perceptual disturbances – F15.129
    - intoxication delirium – F15.121
- moderate or severe
  - with
    - amphetamine (or other stimulant)
      - anxiety disorder – F15.280
      - obsessive-compulsive and related disorder – F15.288
      - sexual dysfunction – F15.281
      - bipolar and related disorder – F15.24
      - depressive disorder – F15.24
      - psychotic disorder – F15.259
    - amphetamine, cocaine, or other stimulant intoxication
      - with perceptual disturbances – F15.222
      - without perceptual disturbances – F15.229
    - intoxication delirium – F15.221
anaerobic glycolysis with anemia – D55.29
anxiety – F41.9
- due to (secondary to)
  - alcohol – F10.980
    - in
      - abuse – F10.180
      - dependence – F10.280
  - amphetamine – F15.980
    - in
      - abuse – F15.180
      - dependence – F15.280
  - anxiolytic – F13.980
    - in
      - abuse – F13.180
      - dependence – F13.280
  - caffeine – F15.980
    - in
      - abuse – F15.180
      - dependence – F15.280
  - cannabis – F12.980
    - in
      - abuse – F12.180
      - dependence – F12.280
  - cocaine – F14.980
    - in
      - abuse – F14.180
      - dependence – F14.180
  - general medical condition – F06.4
  - hallucinogen – F16.980
    - in
      - abuse – F16.180
      - dependence – F16.280
  - hypnotic – F13.980
    - in
      - abuse – F13.180
      - dependence – F13.280
  - inhalant – F18.980
    - in
      - abuse – F18.180
      - dependence – F18.280
  - phencyclidine – F16.980
    - in
      - abuse – F16.180
      - dependence – F16.280
  - psychoactive substance NEC – F19.980
    - in
      - abuse – F19.180
      - dependence – F19.280
  - sedative – F13.980
    - in
      - abuse – F13.180
      - dependence – F13.280
  - volatile solvents – F18.980
    - in
      - abuse – F18.180
      - dependence – F18.280
- generalized – F41.1
- illness – F45.21
- mixed
  - with depression (mild) – F41.8
  - specified NEC – F41.3
- organic – F06.4
- phobic – F40.9
  - of childhood – F40.8
- specified NEC – F41.8
aortic valve – see Endocarditis, aortic
aromatic amino-acid metabolism – E70.9
- specified NEC – E70.89
arteriole NEC – I77.89
artery NEC – I77.89
articulation – see Disorder, joint
attachment (childhood)
- disinhibited – F94.2
- reactive – F94.1
attention-deficit hyperactivity (adolescent) (adult) (child) – F90.9
- combined
  - presentation – F90.2
  - type – F90.2
- hyperactive
  - impulsive presentation – F90.1
  - type – F90.1
- inattentive
  - presentation – F90.0
  - type – F90.0
- specified type NEC – F90.8
attention-deficit without hyperactivity (adolescent) (adult) (child) – F98.8
auditory processing (central) – H93.25
autistic – F84.0
autism spectrum – F84.0
autoimmune – D89.89
autonomic nervous system – G90.9
- specified NEC – G90.89
avoidant
- child or adolescent – F40.10
- restrictive food intake – F50.82
balance
- acid-base – E87.8
  - mixed – E87.4
- electrolyte – E87.8
- fluid NEC – E87.8
behavioral (disruptive) – see Disorder, conduct
bereavement, persistent complex – F43.81
beta-amino-acid metabolism – E72.89
bile acid and cholesterol metabolism – E78.70
- Barth syndrome – E78.71
- other specified – E78.79
- Smith-Lemli-Opitz syndrome – E78.72
bilirubin excretion – E80.6
binge eating – F50.81- (header)
binocular
- movement – H51.9
  - convergence
    - excess – H51.12
    - insufficiency – H51.11
  - internuclear ophthalmoplegia – see Ophthalmoplegia, internuclear
  - palsy of conjugate gaze – H51.0
  - specified type NEC – H51.8
- vision NEC – see Disorder, vision, binocular
bipolar (I) (seasonal) (type 1) – F31.9
- and related due to a known physiological condition
  - with
    - manic features – F06.33
    - manic- or hypomanic-like episodes – F06.33
    - mixed features – F06.34
- current (or most recent)
  - depressed – F31.9
    - with psychotic features – F31.5
    - without psychotic features – F31.30
      - mild – F31.31
      - moderate – F31.32
      - severe (without psychotic features) – F31.4
        with psychotic features – F31.5
  - hypomanic – F31.0
  - manic – F31.9
    - with psychotic features – F31.2
    - without psychotic features – F31.10
      - mild – F31.11
      - moderate – F31.12
      - severe (without psychotic features) – F31.13
        with psychotic features – F31.2
  - mixed – F31.60
    - mild – F31.61
    - moderate – F31.62
    - severe (without psychotic features) – F31.63
      - with psychotic features – F31.64
  - severe depression (without psychotic features) – F31.4
    - with psychotic features – F31.5
- in remission (currently) – F31.70
  - in full remission
    - most recent episode
      - depressed – F31.76
      - hypomanic – F31.72
      - manic – F31.74
      - mixed – F31.78
  - in partial remission
    - most recent episode
      - depressed – F31.75
      - hypomanic – F31.71
      - manic – F31.73
      - mixed – F31.77
- II (type 2) – F31.81
- organic – F06.30
- single manic episode – F30.9
  - mild – F30.11
  - moderate – F30.12
  - severe (without psychotic symptoms) – F30.13
    - with psychotic symptoms – F30.2
- specified NEC – F31.89
bladder – N32.9
- functional NEC – N31.9
- in schistosomiasis – B65.0 – N33 [manifestation]
- specified NEC – N32.89
bleeding – D68.9
blood – D75.9
- in congenital early syphilis – A50.09 – D77 [manifestation]
body dysmorphic – F45.22
bone – M89.9
- continuity – M84.9
  - specified type NEC – M84.80
    - ankle – M84.87- (header)
    - fibula – M84.86- (header)
    - foot – M84.87- (header)
    - hand – M84.84- (header)
    - humerus – M84.82- (header)
    - neck – M84.88
    - pelvis – M84.859
    - radius – M84.83- (header)
    - rib – M84.88
    - shoulder – M84.81- (header)
    - skull – M84.88
    - thigh – M84.85- (header)
    - tibia – M84.86- (header)
    - ulna – M84.83- (header)
    - vertebra – M84.88
- density and structure – M85.9
  - cyst – see also Cyst, bone, specified type NEC
    - aneurysmal – see Cyst, bone, aneurysmal
    - solitary – see Cyst, bone, solitary
  - diffuse idiopathic skeletal hyperostosis – see Hyperostosis, ankylosing
  - fibrous dysplasia (monostotic) – see Dysplasia, fibrous, bone
  - fluorosis – see Fluorosis, skeletal
  - hyperostosis of skull – M85.2
  - osteitis condensans – see Osteitis, condensans
  - specified type NEC – M85.8- (header)
    - ankle – M85.87- (header)
    - foot – M85.87- (header)
    - forearm – M85.83- (header)
    - hand – M85.84- (header)
    - lower leg – M85.86- (header)
    - multiple sites – M85.89
    - neck – M85.88
    - rib – M85.88
    - shoulder – M85.81- (header)
    - skull – M85.88
    - thigh – M85.85- (header)
    - upper arm – M85.82- (header)
    - vertebra – M85.88
- development and growth NEC – M89.20
  - carpus – M89.24- (header)
  - clavicle – M89.21- (header)
  - femur – M89.25- (header)
  - fibula – M89.26- (header)
  - finger – M89.24- (header)
  - humerus – M89.22- (header)
  - ilium – M89.28
  - ischium – M89.28
  - metacarpus – M89.24- (header)
  - metatarsus – M89.27- (header)
  - multiple sites – M89.29
  - neck – M89.28
  - radius – M89.23- (header)
  - rib – M89.28
  - scapula – M89.21- (header)
  - skull – M89.28
  - tarsus – M89.27- (header)
  - tibia – M89.26- (header)
  - toe – M89.27- (header)
  - ulna – M89.23- (header)
  - vertebra – M89.28
- specified type NEC – M89.8X- (header)
brachial plexus – G54.0
branched-chain amino-acid metabolism – E71.2
- specified NEC – E71.19
breast – N64.9
- agalactia – see Agalactia
- associated with
  - lactation – O92.70
    - specified NEC – O92.79
  - pregnancy – O92.20
    - specified NEC – O92.29
  - puerperium – O92.20
    - specified NEC – O92.29
- cracked nipple – see Cracked nipple
- galactorrhea – see Galactorrhea
- hypogalactia – O92.4
- lactation disorder NEC – O92.79
- mastitis – see Mastitis
- nipple infection – see Infection, nipple
- retracted nipple – see Retraction, nipple
- specified type NEC – N64.89
Briquet's – F45.0
bullous, in diseases classified elsewhere – L14
caffeine use
- mild
  - with
    - caffeine-induced
      - anxiety disorder – F15.180
      - sleep disorder – F15.182
- moderate or severe
  - with
    - caffeine-induced
      - anxiety disorder – F15.280
      - sleep disorder – F15.282
cannabis use
- mild – F12.10
  - with
    - cannabis-induced
      - anxiety disorder – F12.180
      - psychotic disorder – F12.159
      - sleep disorder – F12.188
    - cannabis intoxication delirium – F12.121
      - with perceptual disturbances – F12.122
      - without perceptual disturbances – F12.129
  - in remission (early) (sustained) – F12.11
- moderate or severe – F12.20
  - with
    - cannabis-induced
      - anxiety disorder – F12.280
      - psychotic disorder – F12.259
      - sleep disorder – F12.288
    - cannabis intoxication
      - with perceptual disturbances – F12.222
      - without perceptual disturbances – F12.229
    - delirium – F12.221
  - in remission (early) (sustained) – F12.21
carbohydrate
- absorption, intestinal NEC – E74.39
- metabolism (congenital) – E74.9
  - specified NEC – E74.89
cardiac, functional – I51.89
carnitine metabolism – E71.40
cartilage – M94.9
- articular NEC – see Derangement, joint, articular cartilage
  - chondrocalcinosis – see Chondrocalcinosis
- specified type NEC – M94.8X- (header)
  - articular – see Derangement, joint, articular cartilage
  - multiple sites – M94.8X0
catatonia (due to known physiological condition) (with another mental disorder) – F06.1
catatonic NOS – F06.1
- due to (secondary to) – F06.1
- organic NOS – F06.1
central auditory processing – H93.25
cervical
- region NEC – M53.82
- root (nerve) – G54.2
character NOS – F60.9
childhood disintegrative NEC – F84.3
cholesterol and bile acid metabolism – E78.70
- Barth syndrome – E78.71
- other specified – E78.79
- Smith-Lemli-Opitz syndrome – E78.72
choroid – H31.9
- atrophy – see Atrophy, choroid
- degeneration – see Degeneration, choroid
- detachment – see Detachment, choroid
- dystrophy – see Dystrophy, choroid
- hemorrhage – see Hemorrhage, choroid
- rupture – see Rupture, choroid
- scar – see Scar, chorioretinal
- solar retinopathy – see Retinopathy, solar
- specified type NEC – H31.8
ciliary body – see Disorder, iris
- degeneration – see Degeneration, ciliary body
citrate metabolism NEC – E74.829
citrate transporter, SLC13A5 – E74.820
coagulation (factor) – D68.9 – see also Defect, coagulation
- newborn, transient – P61.6
cocaine use
- mild – F14.10
  - with
    - amphetamine, cocaine, or other stimulant intoxication
      - with perceptual disturbances – F14.122
      - without perceptual disturbances – F14.129
    - cocaine-induced
      - anxiety disorder – F14.180
      - bipolar and related disorder – F14.14
      - depressive disorder – F14.14
      - obsessive-compulsive and related disorder – F14.188
      - psychotic disorder – F14.159
      - sexual dysfunction – F14.181
      - sleep disorder – F14.182
    - cocaine intoxication delirium – F14.121
  - in remission (early) (sustained) – F14.11
- moderate or severe – F14.20
  - with
    - amphetamine, cocaine, or other stimulant intoxication
      - with perceptual disturbances – F14.222
      - without perceptual disturbances – F14.229
    - cocaine-induced
      - anxiety disorder – F14.280
      - bipolar and related disorder – F14.24
      - depressive disorder – F14.24
      - obsessive-compulsive and related disorder – F14.288
      - psychotic disorder – F14.259
      - sexual dysfunction – F14.281
      - sleep disorder – F14.282
    - cocaine intoxication delirium – F14.221
  - in remission (early) (sustained) – F14.21
coccyx NEC – M53.3
cognitive – F09
- due to (secondary to) – F09
- persisting – R41.89
  - due to
    - alcohol – F10.97
      - with dependence – F10.27
    - anxiolytics – F13.97
      - with dependence – F13.27
    - hypnotics – F13.97
      - with dependence – F13.27
    - sedatives – F13.97
      - with dependence – F13.27
    - specified substance NEC – F19.97
      - with
        abuse – F19.17
        dependence – F19.27
communication – F80.9
- social pragmatic – F80.82
conduct (childhood) – F91.9
- adjustment reaction – see Disorder, adjustment
- adolescent onset type – F91.2
- childhood onset type – F91.1
- compulsive – F63.9
- confined to family context – F91.0
- depressive – F91.8
- group type – F91.2
- hyperkinetic – see Disorder, attention-deficit hyperactivity
- oppositional defiance – F91.3
- socialized – F91.2
- solitary aggressive type – F91.1
- specified NEC – F91.8
- unsocialized (aggressive) – F91.1
conduction, heart – I45.9
congenital glycosylation (CDG) – E74.89
conjunctiva – H11.9
- infection – see Conjunctivitis
connective tissue, localized – L94.9
- specified NEC – L94.8
conversion (functional neurological symptom disorder)
- with
  - abnormal movement – F44.4
  - anesthesia or sensory loss – F44.6
  - attacks or seizures – F44.5
  - mixed symptoms – F44.7
  - special sensory symptoms – F44.6
  - speech symptoms – F44.4
  - swallowing symptoms – F44.4
  - weakness or paralysis – F44.4
convulsive (secondary) – see Convulsions
cornea – H18.9
- deformity – see Deformity, cornea
- degeneration – see Degeneration, cornea
- deposits – see Deposit, cornea
- due to contact lens – H18.82- (header)
  - specified as edema – see Edema, cornea
- edema – see Edema, cornea
- keratitis – see Keratitis
- keratoconjunctivitis – see Keratoconjunctivitis
- membrane change – see Change, corneal membrane
- neovascularization – see Neovascularization, cornea
- scar – see Opacity, cornea
- specified type NEC – H18.89- (header)
- ulcer – see Ulcer, cornea
corpus cavernosum – N48.9
cranial nerve – see Disorder, nerve, cranial
Cyclin-Dependent Kinase-Like 5 Deficiency (CDKL5) – G40.42
cyclothymic – F34.0
defiant oppositional – F91.3
delusional (persistent) (systematized) – F22
- induced – F24
depersonalization – F48.1
depressive – F32.A
- due to known physiological condition
  - with
    - depressive features – F06.31
    - major depressive-like episode – F06.32
    - mixed features – F06.34
- major – F32.9
  - with psychotic symptoms – F32.3
  - in remission (full) – F32.5
    - partial – F32.4
  - recurrent – F33.9
    - with psychotic features – F33.3
  - single episode – F32.9
    - mild – F32.0
    - moderate – F32.1
    - severe (without psychotic symptoms) – F32.2
      - with psychotic symptoms – F32.3
- organic – F06.31
- persistent – F34.1
- recurrent – F33.9
  - current episode
    - mild – F33.0
    - moderate – F33.1
    - severe (without psychotic symptoms) – F33.2
      - with psychotic symptoms – F33.3
  - in remission – F33.40
    - full – F33.42
    - partial – F33.41
  - specified NEC – F33.8
- single episode – see Episode, depressive
- specified NEC – F32.89
developmental – F89
- arithmetical skills – F81.2
- coordination (motor) – F82
- expressive writing – F81.81
- language – F80.9
  - expressive – F80.1
  - mixed receptive and expressive – F80.2
  - receptive type – F80.2
  - specified NEC – F80.89
- learning – F81.9
  - arithmetical – F81.2
  - reading – F81.0
- mixed – F88
- motor coordination or function – F82
- pervasive – F84.9
  - specified NEC – F84.8
- phonological – F80.0
- reading – F81.0
- scholastic skills – see also Disorder, learning
  - mixed – F81.89
- specified NEC – F88
- speech – F80.9
  - articulation – F80.0
  - specified NEC – F80.89
- written expression – F81.81
diaphragm – J98.6
digestive (system) – K92.9
- newborn – P78.9
  - specified NEC – P78.89
- postprocedural – see Complication, gastrointestinal
- psychogenic – F45.8
disc (intervertebral) – M51.9
- with
  - myelopathy
    - cervical region – M50.00
    - cervicothoracic region – M50.03
    - high cervical region – M50.01
    - lumbar region – M51.06
    - mid-cervical region – M50.020
    - sacrococcygeal region – M53.3
    - thoracic region – M51.04
    - thoracolumbar region – M51.05
  - radiculopathy
    - cervical region – M50.10
    - cervicothoracic region – M50.13
    - high cervical region – M50.11
    - lumbar region – M51.16
    - lumbosacral region – M51.17
    - mid-cervical region – M50.120
    - sacrococcygeal region – M53.3
    - thoracic region – M51.14
    - thoracolumbar region – M51.15
- cervical – M50.90
  - with
    - myelopathy – M50.00
      - C2-C3 – M50.01
      - C3-C4 – M50.01
      - C4-C5 – M50.021
      - C5-C6 – M50.022
      - C6-C7 – M50.023
      - C7-T1 – M50.03
      - cervicothoracic region – M50.03
      - high cervical region – M50.01
      - mid-cervical region – M50.020
    - neuritis, radiculitis or radiculopathy – M50.10
      - C2-C3 – M50.11
      - C3-C4 – M50.11
      - C4-C5 – M50.121
      - C5-C6 – M50.122
      - C6-C7 – M50.123
      - C7-T1 – M50.13
      - cervicothoracic region – M50.13
      - high cervical region – M50.11
      - mid-cervical region – M50.120
  - C2-C3 – M50.91
  - C3-C4 – M50.91
  - C4-C5 – M50.921
  - C5-C6 – M50.922
  - C6-C7 – M50.923
  - C7-T1 – M50.93
  - cervicothoracic region – M50.93
  - degeneration – M50.30
    - C2-C3 – M50.31
    - C3-C4 – M50.31
    - C4-C5 – M50.321
    - C5-C6 – M50.322
    - C6-C7 – M50.323
    - C7-T1 – M50.33
    - cervicothoracic region – M50.33
    - high cervical region – M50.31
    - mid-cervical region – M50.320
  - displacement – M50.20
    - C2-C3 – M50.21
    - C3-C4 – M50.21
    - C4-C5 – M50.221
    - C5-C6 – M50.222
    - C6-C7 – M50.223
    - C7-T1 – M50.23
    - cervicothoracic region – M50.23
    - high cervical region – M50.21
    - mid-cervical region – M50.220
  - high cervical region – M50.91
  - mid-cervical region – M50.920
  - specified type NEC – M50.80
    - C2-C3 – M50.81
    - C3-C4 – M50.81
    - C4-C5 – M50.821
    - C5-C6 – M50.822
    - C6-C7 – M50.823
    - C7-T1 – M50.83
    - cervicothoracic region – M50.83
    - high cervical region – M50.81
    - mid-cervical region – M50.820
- specified NEC
  - lumbar region – M51.86
  - lumbosacral region – M51.87
  - sacrococcygeal region – M53.3
  - thoracic region – M51.84
  - thoracolumbar region – M51.85
disinhibited attachment (childhood) – F94.2
disintegrative, childhood NEC – F84.3
disruptive – F91.9
- mood dysregulation – F34.81
- specified NEC – F91.8
disruptive behavior – see Disorder, conduct
dissocial personality – F60.2
dissociative – F44.9
- affecting
  - motor function – F44.4
    - and sensation – F44.7
  - sensation – F44.6
    - and motor function – F44.7
- brief reactive – F43.0
- due to (secondary to) – F06.8
- mixed – F44.7
- organic – F06.8
- other specified NEC – F44.89
double heterozygous sickling – see Disease, sickle-cell
dream anxiety – F51.5
drug induced hemorrhagic – D68.32
drug related – F19.99
- abuse – see Abuse, drug
- dependence – see Dependence, drug
dysmorphic body – F45.22
dysthymic – F34.1
ear – H93.9- (header)
- bleeding – see Otorrhagia
- deafness – see Deafness
- degenerative – H93.09- (header)
- discharge – see Otorrhea
- external – H61.9- (header)
  - auditory canal stenosis – see Stenosis, external ear canal
  - exostosis – see Exostosis, external ear canal
  - impacted cerumen – see Impaction, cerumen
  - otitis – see Otitis, externa
  - perichondritis – see Perichondritis, ear
  - pinna – see Disorder, pinna
  - specified type NEC – H61.89- (header)
    - in diseases classified elsewhere – H62.8X- (header)
- inner – H83.9- (header)
  - vestibular dysfunction – see Disorder, vestibular function
- middle – H74.9- (header)
  - adhesive – H74.1- (header)
  - ossicle – see Abnormal, ear ossicles
  - polyp – see Polyp, ear (middle)
  - specified NEC, in diseases classified elsewhere – H75.8- (header)
- postprocedural – see Complications, ear, procedure
- specified NEC, in diseases classified elsewhere – H94.8- (header)
eating (adult) (psychogenic) – F50.9
- anorexia – see Anorexia
- binge – F50.81- (header)
- bulimia – F50.2- (header)
- child – F98.29
  - pica (in remission) – F98.3
  - rumination disorder (in remission) – F98.21
- pica – F50.89
  - adult (in remission) – F50.83
  - childhood (in remission) – F98.3
- rumination – R11.10 – see also Rumination
  - adult (in remission) – F50.84
  - infancy or childhood (in remission) – F98.21
- specified NEC – F50.89
electrolyte (balance) – E87.8
- with
  - abortion – see Abortion by type complicated by specified condition NEC
  - ectopic pregnancy – O08.5
  - molar pregnancy – O08.5
- acidosis (lactic) (metabolic) – E87.20
  - acute – E87.21
  - chronic – E87.22
  - respiratory – E87.29
  - specified NEC – E87.29
- alkalosis (metabolic) (respiratory) – E87.3
elimination, transepidermal – L87.9
- specified NEC – L87.8
emotional (persistent) – F34.9
- of childhood – F93.9
  - specified NEC – F93.8
endocrine – E34.9
- postprocedural – E89.89
  - specified NEC – E89.89
erectile (male) (organic) – N52.9 – see also Dysfunction, sexual, male, erectile
- nonorganic – F52.21
erythematous – see Erythema
esophagus – K22.9
- functional – K22.4
- psychogenic – F45.8
eustachian tube – H69.9- (header)
- infection – see Salpingitis, eustachian
- obstruction – see Obstruction, eustachian tube
- patulous – see Patulous, eustachian tube
- specified NEC – H69.8- (header)
exhibitionistic – F65.2
extrapyramidal – G25.9
- in diseases classified elsewhere
- specified type NEC – G25.89
eye – H57.9
- postprocedural – see Complication, postprocedural, eye
eyelid – H02.9
- cyst – see Cyst, eyelid
- degenerative – H02.70
  - chloasma – see Chloasma, eyelid
  - madarosis – see Madarosis
  - specified type NEC – H02.79
  - vitiligo – see Vitiligo, eyelid
  - xanthelasma – see Xanthelasma
- dermatochalasis – see Dermatochalasis
- edema – see Edema, eyelid
- elephantiasis – see Elephantiasis, eyelid
- foreign body, retained – see Foreign body, retained, eyelid
- function – H02.59
  - abnormal innervation syndrome – see Syndrome, abnormal innervation
  - blepharochalasis – see Blepharochalasis
  - blepharoclonus – see Blepharoclonus
  - blepharophimosis – see Blepharophimosis
  - blepharoptosis – see Blepharoptosis
  - lagophthalmos – see Lagophthalmos
  - lid retraction – see Retraction, lid
- hypertrichosis – see Hypertrichosis, eyelid
- specified type NEC – H02.89
- vascular – H02.879
  - left – H02.876
    - lower – H02.875
    - upper – H02.874
  - right – H02.873
    - lower – H02.872
    - upper – H02.871
factitious
- by proxy – F68.A
- imposed on another – F68.A
- imposed on self – F68.10
  - with predominantly
    - psychological symptoms – F68.11
      - with physical symptoms – F68.13
    - physical symptoms – F68.12
      - with psychological symptoms – F68.13
factor, coagulation – see Defect, coagulation
fatty acid
- metabolism – E71.30
  - specified NEC – E71.39
- oxidation
  - LCAD – E71.310
  - MCAD – E71.311
  - SCAD – E71.312
  - specified deficiency NEC – E71.318
feeding (infant or child) – R63.30 – see also Disorder, eating
- pediatric
  - acute – R63.31
  - chronic – R63.32
- or eating disorder – F50.9
- specified NEC – F50.9
feigned (with obvious motivation) – Z76.5
- without obvious motivation – see Disorder, factitious
female
- hypoactive sexual desire – F52.0
- orgasmic – F52.31
- sexual interest/arousal – F52.22
fetishistic – F65.0
fibroblastic – M72.9
- specified NEC – M72.8
fluency
- adult onset – F98.5
- childhood onset – F80.81
- following
  - cerebral infarction – I69.323
  - cerebrovascular disease – I69.923
    - specified disease NEC – I69.823
  - intracerebral hemorrhage – I69.123
  - nontraumatic intracranial hemorrhage NEC – I69.223
  - subarachnoid hemorrhage – I69.023
- in conditions classified elsewhere – R47.82
fluid balance – E87.8
follicular (skin) – L73.9
- specified NEC – L73.8
FOXG1-related – QA0.0151
frotteuristic – F65.81
fructose metabolism – E74.10
- essential fructosuria – E74.11
- fructokinase deficiency – E74.11
- fructose-1, 6-diphosphatase deficiency – E74.19
- hereditary fructose intolerance – E74.12
- other specified – E74.19
functional polymorphonuclear neutrophils – D71.9
- specified NEC – D71.8
gallbladder, biliary tract and pancreas in diseases classified elsewhere – K87
gambling – F63.0
gamma aminobutyric acid (GABA) – E72.81
gamma-glutamyl cycle – E72.89
gastric (functional) – K31.9
- motility – K30
- psychogenic – F45.8
- secretion – K30
gastrointestinal (functional) – K92.9
- newborn – P78.9
- psychogenic – F45.8
gender incongruence – F64.9
- in adolescents and adults – F64.0
- of childhood – F64.2
gender-identity or -role – F64.9
- childhood – F64.2
- effect on relationship – F66
- in remission – F64.A
- of adolescence or adulthood – F64.0
  - nontranssexual – F64.8
- specified NEC – F64.8
- uncertainty – F66
genito-pelvic pain penetration – F52.6
genitourinary system
- female – N94.9
- male – N50.9
- psychogenic – F45.8
globe – H44.9
- degenerated condition – H44.50
  - absolute glaucoma – H44.51- (header)
  - atrophy – H44.52- (header)
  - leucocoria – H44.53- (header)
- degenerative – H44.30
  - chalcosis – H44.31- (header)
  - myopia – H44.2- (header) – see also Myopia, degenerative
  - siderosis – H44.32- (header)
  - specified type NEC – H44.39- (header)
- endophthalmitis – see Endophthalmitis
- foreign body, retained – see Foreign body, intraocular, old, retained
- hemophthalmos – see Hemophthalmos
- hypotony – H44.40
  - due to
    - ocular fistula – H44.42- (header)
    - specified disorder NEC – H44.43- (header)
  - flat anterior chamber – H44.41- (header)
  - primary – H44.44- (header)
- luxation – see Luxation, globe
- specified type NEC – H44.89
glomerular (in) – N05.9
- amyloidosis – E85.4 – N08 [manifestation]
- cryoglobulinemia – D89.1 – N08 [manifestation]
- disseminated intravascular coagulation – D65 – N08 [manifestation]
- Fabry's disease – E75.21 – N08 [manifestation]
- familial lecithin cholesterol acyltransferase deficiency – E78.6 – N08 [manifestation]
- Goodpasture's syndrome – M31.0
- hemolytic-uremic syndrome – see Syndrome, hemolytic-uremic
- Henoch (-Schönlein) – D69.0 – N08 [manifestation]
- malariae malaria – B52.0
- microscopic polyangiitis – M31.7 – N08 [manifestation]
- multiple myeloma – C90.0- (header) – N08 [manifestation]
- mumps – B26.83
- schistosomiasis – B65.9 – N08 [manifestation]
- sepsis NEC – A41.- (header) – N08 [manifestation]
  - streptococcal – A40.- (header) – N08 [manifestation]
- sickle-cell disorders – D57.- (header) – N08 [manifestation]
- strongyloidiasis – B78.9 – N08 [manifestation]
- subacute bacterial endocarditis – I33.0 – N08 [manifestation]
- syphilis – A52.75
- systemic lupus erythematosus – M32.14
- thrombotic thrombocytopenic purpura – M31.19 – N08 [manifestation]
- Waldenström macroglobulinemia – C88.0- (header) – N08 [manifestation]
- Wegener's granulomatosis – M31.31
gluconeogenesis – E74.4
glucosaminoglycan metabolism – see Disorder, metabolism, glucosaminoglycan
glucose transport – E74.819
- specified NEC – E74.818
glycine metabolism – E72.50
- d-glycericacidemia – E72.59
- hyperhydroxyprolinemia – E72.59
- hyperoxaluria – R82.992
  - dietary – E72.540
  - enteric – E72.541
  - primary – E72.539
    - specified type NEC – E72.538
    - type 1 – E72.530
    - type 2 – E72.538
    - type 3 – E72.538
  - secondary – E72.549
    - specified type NEC – E72.548
- hyperprolinemia – E72.59
- non-ketotic hyperglycinemia – E72.51
- oxalosis – E72.53 (header)
- oxaluria – E72.53 (header)
- sarcosinemia – E72.59
- trimethylaminuria – E72.52
glycoprotein metabolism – E77.9
- specified NEC – E77.8
grief
- complicated – F43.81
- prolonged – F43.81
habit (and impulse) – F63.9
- involving sexual behavior NEC – F65.9
- specified NEC – F63.89
hallucinogen use
- mild – F16.10
  - with
    - hallucinogen-induced
      - anxiety disorder – F16.180
      - bipolar and related disorder – F16.14
      - depressive disorder – F16.14
      - psychotic disorder – F16.159
    - hallucinogen intoxication delirium – F16.121
    - other hallucinogen intoxication – F16.129
  - in remission (early) (sustained) – F16.11
- moderate or severe – F16.20
  - with
    - hallucinogen-induced
      - anxiety disorder – F16.280
      - bipolar and related disorder – F16.24
      - depressive disorder – F16.24
      - psychotic disorder – F16.259
    - hallucinogen intoxication delirium – F16.221
    - other hallucinogen intoxication – F16.229
  - in remission (early) (sustained) – F16.21
heart action – I49.9
hematological – D75.9
- newborn (transient) – P61.9
  - specified NEC – P61.8
hematopoietic organs – D75.9
hemorrhagic NEC – D69.9
- drug-induced – D68.32
- due to
  - extrinsic circulating anticoagulants – D68.32
  - increase in
    - anti-IIa – D68.32
    - anti-Xa – D68.32
  - intrinsic
    - circulating anticoagulants – D68.318
    - increase in
      - antithrombin – D68.318
      - anti-VIIIa – D68.318
      - anti-IXa – D68.318
      - anti-XIa – D68.318
- following childbirth – O72.3
hemostasis – see Defect, coagulation
histidine metabolism – E70.40
- histidinemia – E70.41
- other specified – E70.49
hoarding – F42.3
hyperkinetic – see Disorder, attention-deficit hyperactivity
hyperleucine-isoleucinemia – E71.19
hypervalinemia – E71.19
hypoactive sexual desire – F52.0
hypochondriacal – F45.20
- body dysmorphic – F45.22
- neurosis – F45.21
- other specified – F45.29
identity
- dissociative – F44.81
- of childhood – F93.8
- illness anxiety – F45.21
immune mechanism (immunity) – D89.9
- specified type NEC – D89.89
impaired renal tubular function – N25.9
- specified NEC – N25.89
impulse (control) – F63.9
inflammatory
- pelvic, in diseases classified elsewhere
- penis – N48.29
  - abscess – N48.21
  - cellulitis – N48.22
inhalant use
- mild – F18.10
  - with
    - inhalant-induced
      - anxiety disorder – F18.180
      - depressive disorder – F18.14
      - major neurocognitive disorder – F18.17
      - mild neurocognitive disorder – F18.188
      - psychotic disorder – F18.159
    - inhalant intoxication – F18.129
    - inhalant intoxication delirium – F18.121
  - in remission (early) (sustained) – F18.11
- moderate or severe – F18.20
  - with
    - inhalant-induced
      - anxiety disorder – F18.280
      - depressive disorder – F18.24
      - major neurocognitive disorder – F18.27
      - mild neurocognitive disorder – F18.288
      - psychotic disorder – F18.259
    - inhalant intoxication – F18.229
    - inhalant intoxication delirium – F18.221
  - in remission (early) (sustained) – F18.21
integument, newborn – P83.9
- specified NEC – P83.88
intermittent explosive – F63.81
internal secretion pancreas – see Increased, secretion, pancreas, endocrine
intestine, intestinal
- carbohydrate absorption NEC – E74.39
  - postoperative – K91.2
- functional NEC – K59.9
  - postoperative – K91.89
- psychogenic – F45.8
- vascular – K55.9
  - chronic – K55.1
  - specified NEC – K55.8
intraoperative (intraprocedural) – see Complications, intraoperative
involuntary emotional expression (IEED) – F48.2
iris – H21.9
- adhesions – see Adhesions, iris
- atrophy – see Atrophy, iris
- chamber angle recession – see Recession, chamber angle
- cyst – see Cyst, iris
- degeneration – see Degeneration, iris
- in diseases classified elsewhere – H22
- iridodialysis – see Iridodialysis
- iridoschisis – see Iridoschisis
- miotic pupillary cyst – see Cyst, pupillary
- pupillary
  - abnormality – see Abnormality, pupillary
  - membrane – see Membrane, pupillary
- specified type NEC – H21.89
- vascular NEC – H21.1X- (header)
iron metabolism – E83.10
- specified NEC – E83.19
isovaleric acidemia – E71.110
jaw, developmental – M27.0
- temporomandibular – M26.60- (header) – see also Anomaly, dentofacial, temporomandibular joint
joint – M25.9
- derangement – see Derangement, joint
- effusion – see Effusion, joint
- fistula – see Fistula, joint
- hemarthrosis – see Hemarthrosis
- instability – see Instability, joint
- osteophyte – see Osteophyte
- pain – see Pain, joint
- psychogenic – F45.8
- specified type NEC – M25.80
  - ankle – M25.87- (header)
  - elbow – M25.82- (header)
  - foot joint – M25.87- (header)
  - hand joint – M25.84- (header)
  - hip – M25.85- (header)
  - knee – M25.86- (header)
  - shoulder – M25.81- (header)
  - wrist – M25.83- (header)
- stiffness – see Stiffness, joint
ketone metabolism – E71.32
kidney – N28.9
- functional (tubular) – N25.9
- in
  - schistosomiasis – B65.9 – N29 [manifestation]
- tubular function – N25.9
  - specified NEC – N25.89
lacrimal system – H04.9
- changes – H04.69
  - fistula – see Fistula, lacrimal
- gland – H04.19
  - atrophy – see Atrophy, lacrimal gland
  - cyst – see Cyst, lacrimal, gland
  - dacryops – see Dacryops
  - dislocation – see Dislocation, lacrimal gland
  - dry eye syndrome – see Syndrome, dry eye
  - infection – see Dacryoadenitis
- granuloma – see Granuloma, lacrimal
- inflammation – see Inflammation, lacrimal
- obstruction – see Obstruction, lacrimal
- specified NEC – H04.89
lactation NEC – O92.79
language (developmental) – F80.9
- expressive – F80.1
- mixed receptive and expressive – F80.2
- receptive – F80.2
late luteal phase dysphoric – N94.89
learning (specific) – F81.9
- acalculia – R48.8
- alexia – R48.0
- mathematics – F81.2
- reading – F81.0
- specified
  - with impairment in
    - mathematics – F81.2
    - reading – F81.0
    - written expression – F81.81
- specified NEC – F81.89
- spelling – F81.81
- written expression – F81.81
lens – H27.9
- aphakia – see Aphakia
- cataract – see Cataract
- dislocation – see Dislocation, lens
- specified type NEC – H27.8
ligament – M24.20
- ankle – M24.27- (header)
- attachment, spine – see Enthesopathy, spinal
- elbow – M24.22- (header)
- foot joint – M24.27- (header)
- hand joint – M24.24- (header)
- hip – M24.25- (header)
- knee – see Derangement, knee, specified NEC
- shoulder – M24.21- (header)
- specified site NEC – M24.29
- vertebra – M24.28
- wrist – M24.23- (header)
ligamentous attachments – see also Enthesopathy
- spine – see Enthesopathy, spinal
lipid
- metabolism, congenital – E78.9
- storage – E75.6
  - specified NEC – E75.5
lipoprotein
- deficiency (familial) – E78.6
- metabolism – E78.9
  - specified NEC – E78.89
liver – K76.9
- malarial – B54 – K77 [manifestation]
low back – see also Dorsopathy, specified NEC
lumbosacral
- plexus – G54.1
- root (nerve) – G54.4
lung, interstitial, drug-induced – J70.4
- acute – J70.2
- chronic – J70.3
- dabbing (related) – U07.0
- e-cigarette (related) – U07.0
- electronic cigarette (related) – U07.0
- vaping (associated) (device) (product) (related) (use) – U07.0
lymphoproliferative, post-transplant (PTLD) – D47.Z1
lysine and hydroxylysine metabolism – E72.3
major neurocognitive – F03- (header) – see also Dementia, in (due to)
male
- erectile (organic) – N52.9 – see also Dysfunction, sexual, male, erectile
  - nonorganic – F52.21
- hypoactive sexual desire – F52.0
- orgasmic – F52.32
manic – F30.9
- organic – F06.33
mast cell activation – see Activation, mast cell
mastoid – see also Disorder, ear, middle
- postprocedural – see Complications, ear, procedure
meninges, specified type NEC – G96.198
meniscus – see Derangement, knee, meniscus
menopausal – N95.9
- specified NEC – N95.8
menstrual – N92.6
- psychogenic – F45.8
- specified NEC – N92.5
mental (or behavioral) (nonpsychotic) – F99
- due to (secondary to)
  - amphetamine
    - due to drug abuse – see Abuse, drug, stimulant
    - due to drug dependence – see Dependence, drug, stimulant
  - brain disease, damage and dysfunction – F09
  - caffeine use
    - due to drug abuse – see Abuse, drug, stimulant
    - due to drug dependence – see Dependence, drug, stimulant
  - cannabis use
    - due to drug abuse – see Abuse, drug, cannabis
    - due to drug dependence – see Dependence, drug, cannabis
  - general medical condition – F09
  - sedative or hypnotic use
    - due to drug abuse – see Abuse, drug, sedative
    - due to drug dependence – see Dependence, drug, sedative
  - tobacco (nicotine) – see Dependence, drug, nicotine
- following organic brain damage – F07.9
  - frontal lobe syndrome – F07.0
  - personality change – F07.0
  - postconcussional syndrome – F07.81
  - specified NEC – F07.89
- infancy, childhood or adolescence – F98.9
- neurotic – see Neurosis
- organic or symptomatic – F09
- presenile, psychotic – F03 (header)
- problem NEC
- psychoneurotic – see Neurosis
- psychotic – see Psychosis
- puerperal – F53.0
- senile, psychotic NEC – F03 (header)
metabolic, amino acid, transitory, newborn – P74.8
metabolism NOS – E88.9
- amino-acid – E72.9
  - aromatic – E70.9
    - albinism – see Albinism
    - histidine – E70.40
      - histidinemia – E70.41
      - other specified – E70.49
    - hyperphenylalaninemia – E70.1
      - classical phenylketonuria – E70.0
    - other specified – E70.89
    - tryptophan – E70.5
    - tyrosine – E70.20
      - hypertyrosinemia – E70.21
      - other specified – E70.29
  - branched chain – E71.2
    - 3-methylglutaconic aciduria – E71.111
    - hyperleucine-isoleucinemia – E71.19
    - hypervalinemia – E71.19
    - isovaleric acidemia – E71.110
    - maple syrup urine disease – E71.0
    - methylmalonic acidemia – E71.120
    - organic aciduria NEC – E71.118
    - other specified – E71.19
    - propionate NEC – E71.128
    - propionic acidemia – E71.121
  - glycine – E72.50
    - d-glycericacidemia – E72.59
    - hyperhydroxyprolinemia – E72.59
    - hyperoxaluria – R82.992
      - primary – E72.53 (header)
    - hyperprolinemia – E72.59
    - non-ketotic hyperglycinemia – E72.51
    - other specified – E72.59
    - sarcosinemia – E72.59
    - trimethylaminuria – E72.52
  - hydroxylysine – E72.3
  - lysine – E72.3
  - ornithine – E72.4
  - other specified – E72.89
    - beta-amino acid – E72.89
    - gamma-glutamyl cycle – E72.89
  - straight-chain – E72.89
  - sulfur-bearing – E72.10
    - homocystinuria – E72.11
    - methylenetetrahydrofolate reductase deficiency – E72.12
    - other specified – E72.19
- bile acid and cholesterol metabolism – E78.70
- bilirubin – E80.7
  - specified NEC – E80.6
- calcium – E83.50
  - hypercalcemia – E83.52
  - hypocalcemia – E83.51
  - other specified – E83.59
- carbohydrate – E74.9
  - specified NEC – E74.89
- cholesterol and bile acid metabolism – E78.70
- citrate NEC – E74.829
- congenital – E88.9
- copper – E83.00
  - Wilson's disease – E83.01
  - specified type NEC – E83.09
- cystinuria – E72.01
- fructose – E74.10
- galactose – E74.20
- glucosaminoglycan – E76.9
  - mucopolysaccharidosis – see Mucopolysaccharidosis
  - specified NEC – E76.8
- glutamine – E72.89
- glycine – E72.50
- glycogen storage (hepatorenal) – E74.09
- glycoprotein – E77.9
  - specified NEC – E77.8
- glycosaminoglycan – E76.9
  - specified NEC – E76.8
- in labor and delivery – O75.89
- iron – E83.10
- isoleucine – E71.19
- leucine – E71.19
- lipoid – E78.9
- lipoprotein – E78.9
  - specified NEC – E78.89
- magnesium – E83.40
  - hypermagnesemia – E83.41
  - hypomagnesemia – E83.42
  - other specified – E83.49
- mineral – E83.9
  - specified NEC – E83.89
- mitochondrial – E88.40
  - aminoacyl-tRNA synthetase – E88.43
  - ARS2-related – E88.43
  - MELAS syndrome – E88.41
  - MERRF syndrome (myoclonic epilepsy associated with ragged-red fibers) – E88.42
  - other specified – E88.49
  - tRNA synthetases – E88.43
- ornithine – E72.4
- phosphatases – E83.30
- phosphorus – E83.30
  - acid phosphatase deficiency – E83.39
  - hypophosphatasia – E83.39
  - hypophosphatemia – E83.39
    - familial – E83.31
  - other specified – E83.39
  - pseudovitamin D deficiency – E83.32
- plasma protein NEC – E88.09
- porphyrin – see Porphyria
- postprocedural – E89.89
  - specified NEC – E89.89
- purine – E79.9
  - specified NEC – E79.89
- pyrimidine – E79.9
  - specified NEC – E79.89
- pyruvate – E74.4
- serine – E72.89
- sodium – E87.8
- specified NEC – E88.89
- threonine – E72.89
- valine – E71.19
- zinc – E83.2
methylmalonic acidemia – E71.120
micturition NEC – R39.198 – see also Difficulty, micturition
- feeling of incomplete emptying – R39.14
- hesitancy – R39.11
- poor stream – R39.12
- psychogenic – F45.8
- split stream – R39.13
- straining – R39.16
- urgency – R39.15
mild neurocognitive – G31.84
- due to known physiological condition (without behavioral disturbance) – F06.70
  - with behavioral disturbance – F06.71
mitochondrial metabolism – E88.40
mitral (valve) – see Endocarditis, mitral
mixed
- anxiety and depressive – F41.8
- of scholastic skills (developmental) – F81.89
- receptive expressive language – F80.2
mood – F39
- bipolar – see Disorder, bipolar
- depressive – see Disorder, depressive
- due to (secondary to)
  - alcohol – F10.94
  - amphetamine – F15.94
    - in
      - abuse – F15.14
      - dependence – F15.24
  - anxiolytic – F13.94
    - in
      - abuse – F13.14
      - dependence – F13.24
  - cocaine – F14.94
    - in
      - abuse – F14.14
      - dependence – F14.24
  - general medical condition – F06.30
  - hallucinogen – F16.94
    - in
      - abuse – F16.14
      - dependence – F16.24
  - hypnotic – F13.94
    - in
      - abuse – F13.14
      - dependence – F13.24
  - inhalant – F18.94
    - in
      - abuse – F18.14
      - dependence – F18.24
  - opioid – F11.94
    - in
      - abuse – F11.14
      - dependence – F11.24
  - phencyclidine (PCP) – F16.94
    - in
      - abuse – F16.14
      - dependence – F16.24
  - physiological condition – F06.30
    - with
      - depressive features – F06.31
      - major depressive-like episode – F06.32
      - manic features – F06.33
      - mixed features – F06.34
  - psychoactive substance NEC – F19.94
    - in
      - abuse – F19.14
      - dependence – F19.24
  - sedative – F13.94
    - in
      - abuse – F13.14
      - dependence – F13.24
  - volatile solvents – F18.94
    - in
      - abuse – F18.14
      - dependence – F18.24
- manic episode – F30.9
  - with psychotic symptoms – F30.2
  - in remission (full) – F30.4
    - partial – F30.3
  - specified type NEC – F30.8
  - without psychotic symptoms – F30.10
    - mild – F30.11
    - moderate – F30.12
    - severe – F30.13
- organic – F06.30
  - right hemisphere – F07.89
- persistent – F34.9
  - cyclothymia – F34.0
  - dysthymia – F34.1
  - specified type NEC – F34.89
- recurrent – F39
- right hemisphere organic – F07.89
movement – G25.9
- drug-induced – G25.70
  - akathisia – G25.71
  - specified NEC – G25.79
- hysterical – F44.4
- in diseases classified elsewhere
- periodic limb – G47.61
  - sleep related – G47.61
- specified NEC – G25.89
- sleep related NEC – G47.69
- stereotyped – F98.4
- treatment-induced – G25.9
multiple personality – F44.81
muscle – M62.9
- attachment, spine – see Enthesopathy, spinal
- in trichinellosis – see Trichinellosis, with muscle disorder
- psychogenic – F45.8
- specified type NEC – M62.89
- tone, newborn – P94.9
  - specified NEC – P94.8
muscular
- attachments – see also Enthesopathy
  - spine – see Enthesopathy, spinal
- urethra – N36.44
musculoskeletal system, soft tissue – see Disorder, soft tissue
- postprocedural – M96.89
- psychogenic – F45.8
myoneural – G70.9
- due to lead – G70.1
- specified NEC – G70.89
- toxic – G70.1
myotonic NEC – G71.19
nail, in diseases classified elsewhere – L62
neck region NEC – see Dorsopathy, specified NEC
neonatal onset multisystemic inflammatory (NOMID) – M04.2
nerve – G58.9
- abducent NEC – see Strabismus, paralytic, sixth nerve
- accessory – G52.8
- acoustic
- auditory
- auriculotemporal – G50.8
- axillary – G54.0
- cerebral – see Disorder, nerve, cranial
- cranial – G52.9
  - eighth
  - eleventh – G52.8
  - fifth – G50.9
  - first – G52.0
  - fourth NEC – see Strabismus, paralytic, fourth nerve
  - multiple – G52.7
  - ninth – G52.1
  - second NEC – see Disorder, nerve, optic
  - seventh NEC – G51.8
  - sixth NEC – see Strabismus, paralytic, sixth nerve
  - specified NEC – G52.8
  - tenth – G52.2
  - third NEC – see Strabismus, paralytic, third nerve
  - twelfth – G52.3
- entrapment – see Neuropathy, entrapment
- facial – G51.9
  - specified NEC – G51.8
- femoral – see Lesion, nerve, femoral
- glossopharyngeal NEC – G52.1
- hypoglossal – G52.3
- intercostal – G58.0
- lateral
  - cutaneous of thigh – see Mononeuropathy, lower limb, meralgia paresthetica
  - popliteal – see Lesion, nerve, popliteal
- lower limb – see Mononeuropathy, lower limb
- medial popliteal – see Lesion, nerve, popliteal, medial
- median NEC – see Lesion, nerve, median
- multiple – G58.7
- oculomotor NEC – see Strabismus, paralytic, third nerve
- olfactory – G52.0
- optic NEC – H47.09- (header)
  - hemorrhage into sheath – see Hemorrhage, optic nerve
  - ischemic – H47.01- (header)
- peroneal – see Lesion, nerve, popliteal
- phrenic – G58.8
- plantar – see Lesion, nerve, plantar
- pneumogastric – G52.2
- posterior tibial – see Syndrome, tarsal tunnel
- radial – see Lesion, nerve, radial
- recurrent laryngeal – G52.2
- root – G54.9
  - cervical – G54.2
  - lumbosacral – G54.1
  - specified NEC – G54.8
  - thoracic – G54.3
- sciatic NEC – see Lesion, nerve, sciatic
- specified NEC – G58.8
  - lower limb – see Mononeuropathy, lower limb, specified NEC
  - upper limb – see Mononeuropathy, upper limb, specified NEC
- sympathetic – G90.9
- tibial – see Lesion, nerve, popliteal, medial
- trigeminal – G50.9
  - specified NEC – G50.8
- trochlear NEC – see Strabismus, paralytic, fourth nerve
- ulnar – see Lesion, nerve, ulnar
- upper limb – see Mononeuropathy, upper limb
- vagus – G52.2
nervous system – G98.8
- autonomic (peripheral) – G90.9
  - specified NEC – G90.89
- central – G96.9
  - specified NEC – G96.89
- parasympathetic – G90.9
- specified NEC – G98.8
- sympathetic – G90.9
- vegetative – G90.9
neurocognitive – R41.9
- with Lewy bodies – G31.83 – F02.- (header) [manifestation] – see also Dementia, in, diseases specified elsewhere
- frontotemporal, specified NEC – G31.09 – F02.- (header) [manifestation] – see also Dementia, in, diseases specified elsewhere
- major – F03.- (header) – see also Dementia
  - due to vascular disease – see Dementia, vascular
    - mild – see Dementia, vascular, mild
    - moderate – see Dementia, vascular, moderate
    - severe – see Dementia, vascular, severe
  - in (due to) (other diseases classified elsewhere) – F02.80 – see also Dementia, in (due to)
    - with
      - aggressive behavior – F02.81- (header) – see also Dementia, in (due to)
      - combative behavior – F02.81- (header) – see also Dementia, in (due to)
      - violent behavior – F02.81- (header) – see also Dementia, in (due to)
- mild (of uncertain or unknown etiology) – G31.84 – see also Disorder, mild neurocognitive
neurodevelopmental – F89
- CACNA1A-related – QA0.0102
- DLG4-related synaptopathy – QA0.0142
- FOXG1-related – QA0.0151
- GRIN1-related – QA0.011
- GRIN2A-related – QA0.011
- GRIN2B-related – QA0.011
- GRIN2D-related – QA0.011
- GRIA1-related – QA0.011
- GRIA2-related – QA0.011
- GRIA3-related – QA0.011
- GRIA4-related – QA0.011
- GRIK2-related – QA0.011
- other
  - glutamate receptor, ionotropic, related – QA0.011
  - ion channel gene related – QA0.0109
  - receptor gene related – QA0.012
  - related to other genes associated with transcription and gene expression – QA0.0159
  - synapse related gene – QA0.0149
  - transporter or solute carrier gene related – QA0.0139
- SCN2A-related – QA0.0101
- SLC6A1-related – QA0.0131
- STXBP1-related – QA0.0141
- syntaxin-binding protein 1-related – QA0.0141
- specified NEC – F88
  - related to pathogenic variants in specific genes NEC – QA0.8
neurohypophysis NEC – E23.3
neurological NEC – R29.818
- TUBB4A-related – G23.3
neuromuscular – G70.9
- hereditary NEC – G71.9
- specified NEC – G70.89
- toxic – G70.1
neurotic – F48.9
- specified NEC – F48.8
neutrophil, polymorphonuclear – D71.9
- specified NEC – D71.8
nicotine use – see Dependence, drug, nicotine
nightmare – F51.5
non-rapid eye movement sleep arousal
- sleep terror type – F51.4
- sleepwalking type – F51.3
nose – J34.9
- specified NEC – J34.89
obsessive-compulsive – F42.9
- and related disorder due to a known physiological condition – F06.8
odontogenesis NOS – K00.9
opioid use
- with
  - opioid-induced psychotic disorder – F11.959
    - with
      - delusions – F11.950
      - hallucinations – F11.951
- due to drug abuse – see Abuse, drug, opioid
- due to drug dependence – see Dependence, drug, opioid
- mild – F11.10
  - with
    - opioid-induced
      - anxiety disorder – F11.188
      - depressive disorder – F11.14
      - sexual dysfunction – F11.181
    - opioid intoxication
      - with perceptual disturbances – F11.122
      - delirium – F11.121
      - without perceptual disturbances – F11.129
  - in remission (early) (sustained) – F11.11
- moderate or severe – F11.20
  - with
    - opioid-induced
      - anxiety disorder – F11.288
      - depressive disorder – F11.24
      - sexual dysfunction – F11.281
    - opioid intoxication
      - with perceptual disturbances – F11.222
      - delirium – F11.221
      - without perceptual disturbances – F11.229
  - in remission (early) (sustained) – F11.21
oppositional defiant – F91.3
optic
- chiasm – H47.49
  - due to
    - inflammatory disorder – H47.41
    - neoplasm – H47.42
    - vascular disorder – H47.43
- disc – H47.39- (header)
  - coloboma – see Coloboma, optic disc
  - drusen – see Drusen, optic disc
  - pseudopapilledema – see Pseudopapilledema
- radiations – see Disorder, visual, pathway
- tracts – see Disorder, visual, pathway
orbit – H05.9
- cyst – see Cyst, orbit
- deformity – see Deformity, orbit
- edema – see Edema, orbit
- enophthalmos – see Enophthalmos
- exophthalmos – see Exophthalmos
- hemorrhage – see Hemorrhage, orbit
- inflammation – see Inflammation, orbit
- myopathy – see Myopathy, extraocular muscles
- retained foreign body – see Foreign body, orbit, old
- specified type NEC – H05.89
organic
- anxiety – F06.4
- catatonic NOS – F06.1
- delusional – F06.2
- dissociative – F06.8
- emotionally labile (asthenic) – F06.8
- mood (affective) – F06.30
- schizophrenia-like – F06.2
orgasmic (female) – F52.31
- male – F52.32
ornithine metabolism – E72.4
overanxious – F41.1
- of childhood – F93.8
pain
- with related psychological factors – F45.42
- exclusively related to psychological factors – F45.41
- genito-pelvic penetration disorder – F52.6
pancreatic internal secretion – E16.9
- specified NEC – E16.8
panic – F41.0
- with agoraphobia – F40.01
papulosquamous – L44.9
- in diseases classified elsewhere – L45
- specified NEC – L44.8
paranoid – F22
- induced – F24
- shared – F24
paraphilic – F65.9
- specified NEC – F65.89
parathyroid (gland) – E21.5
- specified NEC – E21.4
parietoalveolar NEC – J84.09
paroxysmal, mixed – R56.9
patella – M22.9- (header)
- chondromalacia – see Chondromalacia, patella
- derangement NEC – M22.3X- (header)
- recurrent
  - dislocation – see Dislocation, patella, recurrent
  - subluxation – see Dislocation, patella, recurrent, incomplete
- specified NEC – M22.8X- (header)
patellofemoral – M22.2X- (header)
pedophilic – F65.4
pentose phosphate pathway with anemia – D55.1
perception, due to hallucinogens – F16.983
- in
  - abuse – F16.183
  - dependence – F16.283
peripheral nervous system NEC – G64
peroxisomal – E71.50
- biogenesis
  - neonatal adrenoleukodystrophy – E71.511
  - specified disorder NEC – E71.518
  - Zellweger syndrome – E71.510
- rhizomelic chondrodysplasia punctata – E71.540
- specified form NEC – E71.548
  - group 1 – E71.518
  - group 2 – E71.53
  - group 3 – E71.542
- X-linked adrenoleukodystrophy – E71.529
  - adolescent – E71.521
  - adrenomyeloneuropathy – E71.522
  - childhood – E71.520
  - specified form NEC – E71.528
- Zellweger-like syndrome – E71.541
persistent
- (somatoform) – F45.41
- affective (mood) – F34.9
personality – F60.9 – see also Personality
- affective – F34.0
- aggressive – F60.3
- amoral – F60.2
- anankastic – F60.5
- antisocial – F60.2
- anxious – F60.6
- asocial – F60.2
- asthenic – F60.7
- avoidant – F60.6
- borderline – F60.3
- change (secondary) – F07.0
- compulsive – F60.5
- cyclothymic – F34.0
- dependent (passive) – F60.7
- depressive – F34.1
- dissocial – F60.2
- emotional instability – F60.3
- expansive paranoid – F60.0
- explosive – F60.3
- following organic brain damage – F07.9
- histrionic – F60.4
- hyperthymic – F34.0
- hypothymic – F34.1
- hysterical – F60.4
- immature – F60.89
- inadequate – F60.7
- labile – F60.3
- mixed (nonspecific) – F60.89
- moral deficiency – F60.2
- narcissistic – F60.81
- negativistic – F60.89
- obsessional – F60.5
- obsessive (-compulsive) – F60.5
- organic – F07.9
- overconscientious – F60.5
- paranoid – F60.0
- passive (-dependent) – F60.7
- passive-aggressive – F60.89
- pathological NEC – F60.9
- pseudosocial – F60.2
- psychopathic – F60.2
- schizoid – F60.1
- schizotypal – F21
- self-defeating – F60.7
- specified NEC – F60.89
- type A – F60.5
- unstable (emotional) – F60.3
pervasive, developmental – F84.9
phencyclidine use
- mild – F16.10
  - with
    - phencyclidine-induced
      - anxiety disorder – F16.180
      - bipolar and related disorder – F16.14
      - depressive disorder – F16.14
      - psychotic disorder – F16.159
    - phencyclidine intoxication – F16.129
    - phencyclidine intoxication delirium – F16.121
  - in remission (early) (sustained) – F16.11
- moderate or severe – F16.20
  - with
    - phencyclidine-induced
      - anxiety disorder – F16.280
      - bipolar and related disorder – F16.24
      - depressive disorder – F16.24
      - psychotic disorder – F16.259
    - phencyclidine intoxication – F16.229
    - phencyclidine intoxication delirium – F16.221
  - in remission (early) (sustained) – F16.21
phobic anxiety, childhood – F40.8
phosphate-losing tubular – N25.0
pigmentation – L81.9
- choroid, congenital – Q14.3
- diminished melanin formation – L81.6
- iron – L81.8
- specified NEC – L81.8
pinna (noninfective) – H61.10- (header)
- deformity, acquired – H61.11- (header)
- hematoma – H61.12- (header)
- perichondritis – see Perichondritis, ear
- specified type NEC – H61.19- (header)
pituitary gland – E23.7
- iatrogenic (postprocedural) – E89.3
- specified NEC – E23.6
platelet-activating anti-PF4, specified NEC – D75.84
platelets – D69.19
plexus – G54.9
- specified NEC – G54.8
polymorphonuclear neutrophils – D71.9
- specified NEC – D71.8
porphyrin metabolism – see Porphyria
postconcussional – F07.81
posthallucinogen perception – F16.983
- in
  - abuse – F16.183
  - dependence – F16.283
postmenopausal – N95.9
- specified NEC – N95.8
postprocedural (postoperative) – see Complications, postprocedural
post-transplant lymphoproliferative – D47.Z1
post-traumatic stress (PTSD) – F43.10
- acute – F43.11
- chronic – F43.12
premenstrual dysphoric (PMDD) – F32.81
prepuce – N47.8
propionic acidemia – E71.121
prostate – N42.9
- specified NEC – N42.89
psychogenic NOS – F45.9 – see also condition
- anxiety – F41.8
- appetite – F50.9
- asthenic – F48.8
- cardiovascular (system) – F45.8
- compulsive – F42.8
- cutaneous – F54
- depressive – F32.9
- digestive (system) – F45.8
- dysmenorrheic – F45.8
- dyspneic – F45.8
- endocrine (system) – F54
- eye NEC – F45.8
- feeding – see Disorder, eating
- functional NEC – F45.8
- gastric – F45.8
- gastrointestinal (system) – F45.8
- genitourinary (system) – F45.8
- heart (function) (rhythm) – F45.8
- hyperventilatory – F45.8
- hypochondriacal – see Disorder, hypochondriacal
- intestinal – F45.8
- joint – F45.8
- learning – F81.9
- limb – F45.8
- lymphatic (system) – F45.8
- menstrual – F45.8
- micturition – F45.8
- monoplegic NEC – F44.4
- motor – F44.4
- muscle – F45.8
- musculoskeletal – F45.8
- neurocirculatory – F45.8
- obsessive – F42.8
- occupational – F48.8
- organ or part of body NEC – F45.8
- paralytic NEC – F44.4
- phobic – F40.9
- physical NEC – F45.8
- rectal – F45.8
- respiratory (system) – F45.8
- rheumatic – F45.8
- sexual (function) – F52.9
- skin (allergic) (eczematous) – F54
- sleep – F51.9
- specified part of body NEC – F45.8
- stomach – F45.8
psychological – F99
- associated with
  - disease classified elsewhere – F54
  - sexual
    - development – F66
    - relationship – F66
  - uncertainty about gender identity – F64.9
psychomotor NEC – F44.4
- hysterical – F44.4
psychoneurotic – see also Neurosis
- mixed NEC – F48.8
psychophysiologic – see Disorder, somatoform
psychosexual – F65.9
- development – F66
- identity of childhood – F64.2
psychosomatic NOS – see Disorder, somatoform
- multiple – F45.0
- undifferentiated – F45.1
psychotic – see Psychosis
- transient (acute) – F23
puberty – E30.9
- specified NEC – E30.8
pulmonary (valve) – see Endocarditis, pulmonary
purine metabolism – E79.9
pyrimidine metabolism – E79.9
pyruvate metabolism – E74.4
reactive attachment (childhood) – F94.1
reading – R48.0
- developmental (specific) – F81.0
receptive language – F80.2
receptor, hormonal, peripheral – E34.50 – see also Syndrome, androgen insensitivity
recurrent brief depressive – F33.8
reflex – R29.2
refraction – H52.7
- aniseikonia – H52.32
- anisometropia – H52.31
- astigmatism – see Astigmatism
- hypermetropia – see Hypermetropia
- myopia – see Myopia
- presbyopia – H52.4
- specified NEC – H52.6
relationship – F68.8
- due to sexual orientation – F66
REM sleep behavior – G47.52
renal function, impaired (tubular) – N25.9
resonance – R49.9
- specified NEC – R49.8
respiratory function, impaired – see also Failure, respiration
- postprocedural – see Complication, postoperative, respiratory system
- psychogenic – F45.8
retina – H35.9
- angioid streaks – H35.33
- changes in vascular appearance – H35.01- (header)
- degeneration – see Degeneration, retina
- dystrophy (hereditary) – see Dystrophy, retina
- edema – H35.81
- hemorrhage – see Hemorrhage, retina
- ischemia – H35.82
- macular degeneration – see Degeneration, macula
- microaneurysms – H35.04- (header)
- microvascular abnormality NEC – H35.09
- neovascularization – see Neovascularization, retina
- retinopathy – see Retinopathy
- separation of layers – H35.70
  - central serous chorioretinopathy – H35.71- (header)
  - pigment epithelium detachment (serous) – H35.72- (header)
    - hemorrhagic – H35.73- (header)
- specified type NEC – H35.89
- telangiectasis – see Telangiectasis, retina
- vasculitis – see Vasculitis, retina
retroperitoneal – K68.9
right hemisphere organic affective – F07.89
rumination (infant or child) (in remission) – F98.21
- adult (in remission) – F50.84
sacrum, sacrococcygeal NEC – M53.3
schizoaffective – F25.9
- bipolar type – F25.0
- depressive type – F25.1
- manic type – F25.0
- mixed type – F25.0
- specified NEC – F25.8
schizoid of childhood – F84.5
schizophrenia spectrum and other psychotic disorder – F29
- specified NEC – F28
schizophreniform – F20.81
- brief – F23
schizotypal (personality) – F21
seasonal affective, recurrent episodes – F33.- (header)
secretion, thyrocalcitonin – E07.0
sedative, hypnotic, or anxiolytic use
- mild – F13.10
  - with
    - sedative, hypnotic, or anxiolytic-induced
      - anxiety disorder – F13.180
      - bipolar and related disorder – F13.14
      - depressive disorder – F13.14
      - psychotic disorder – F13.159
      - sexual dysfunction – F13.181
    - sedative, hypnotic, or anxiolytic intoxication – F13.129
    - sedative, hypnotic, or anxiolytic intoxication delirium – F13.121
  - in remission (early) (sustained) – F13.11
- moderate or severe – F13.20
  - with
    - sedative, hypnotic, or anxiolytic-induced
      - anxiety disorder – F13.280
      - bipolar and related disorder – F13.24
      - depressive disorder – F13.24
      - major neurocognitive disorder – F13.27
      - mild neurocognitive disorder – F13.288
      - psychotic disorder – F13.259
      - sexual dysfunction – F13.281
    - sedative, hypnotic, or anxiolytic intoxication – F13.229
    - sedative, hypnotic, or anxiolytic intoxication delirium – F13.221
  - in remission (early) (sustained) – F13.21
seizure – G40.909 – see also Epilepsy
- intractable – G40.919
  - with status epilepticus – G40.911
semantic pragmatic – F80.89
- with autism – F84.0
sense of smell – R43.1
- psychogenic – F45.8
separation anxiety, of childhood – F93.0
sexual
- arousal, female – F52.22
- aversion – F52.1
- function, psychogenic – F52.9
- interest/arousal, female – F52.22
- masochism – F65.51
- maturation – F66
- nonorganic – F52.9
- preference – F65.9 – see also Deviation, sexual
  - fetishistic transvestism – F65.1
- relationship – F66
- sadism – F65.52
shyness, of childhood and adolescence – F40.10
sibling rivalry – F93.8
sickle-cell (sickling) (homozygous) – see Disease, sickle-cell
- heterozygous – D57.3
- specified type NEC – D57.8- (header)
- trait – D57.3
sinus (nasal) – J34.9
- specified NEC – J34.89
skin – L98.9
- atrophic – L90.9
  - specified NEC – L90.8
- granulomatous – L92.9
  - specified NEC – L92.8
- hypertrophic – L91.9
  - specified NEC – L91.8
- infiltrative NEC – L98.6
- newborn – P83.9
  - specified NEC – P83.88
- picking – F42.4
- psychogenic (allergic) (eczematous) – F54
SLC13A5 Citrate Transporter Disorder – E74.820
sleep – G47.9
- breathing-related – see Apnea, sleep
- circadian rhythm – G47.20
  - advance sleep phase type – G47.22
  - delayed sleep phase type – G47.21
  - due to
    - alcohol
      - abuse – F10.182
      - dependence – F10.282
      - use – F10.982
    - amphetamines
      - abuse – F15.182
      - dependence – F15.282
      - use – F15.982
    - caffeine
      - abuse – F15.182
      - dependence – F15.282
      - use – F15.982
    - cocaine
      - abuse – F14.182
      - dependence – F14.282
      - use – F14.982
    - drug NEC
      - abuse – F19.182
      - dependence – F19.282
      - use – F19.982
    - opioid
      - abuse – F11.182
      - dependence – F11.282
      - use – F11.982
    - psychoactive substance NEC
      - abuse – F19.182
      - dependence – F19.282
      - use – F19.982
    - sedative, hypnotic, or anxiolytic
      - abuse – F13.182
      - dependence – F13.282
      - use – F13.982
    - stimulant NEC
      - abuse – F15.182
      - dependence – F15.282
      - use – F15.982
  - free running type – G47.24
  - in conditions classified elsewhere – G47.27
  - irregular sleep wake type – G47.23
  - jet lag type – G47.25
  - non-24-hour sleep-wake type – G47.24
  - shift work type – G47.26
  - specified NEC – G47.29
- due to
  - alcohol
    - abuse – F10.182
    - dependence – F10.282
    - use – F10.982
  - amphetamine
    - abuse – F15.182
    - dependence – F15.282
    - use – F15.982
  - anxiolytic
    - abuse – F13.182
    - dependence – F13.282
    - use – F13.982
  - caffeine
    - abuse – F15.182
    - dependence – F15.282
    - use – F15.982
  - cocaine
    - abuse – F14.182
    - dependence – F14.282
    - use – F14.982
  - drug NEC
    - abuse – F19.182
    - dependence – F19.282
    - use – F19.982
  - hypnotic
    - abuse – F13.182
    - dependence – F13.282
    - use – F13.982
  - opioid
    - abuse – F11.182
    - dependence – F11.282
    - use – F11.982
  - psychoactive substance NEC
    - abuse – F19.182
    - dependence – F19.282
    - use – F19.982
  - sedative
    - abuse – F13.182
    - dependence – F13.282
    - use – F13.982
  - stimulant NEC
    - abuse – F15.182
    - dependence – F15.282
    - use – F15.982
- emotional – F51.9
- excessive somnolence – see Hypersomnia
- hypersomnia type – see Hypersomnia
- initiating or maintaining – see Insomnia
- nightmares – F51.5
- nonorganic – F51.9
  - specified NEC – F51.8
- parasomnia type – G47.50
- specified NEC – G47.8
- terrors – F51.4
- walking – F51.3
sleep-wake pattern or schedule – G47.9 – see also Disorder, sleep, circadian rhythm
- specified NEC – G47.8
social
- anxiety (of childhood) – F40.10
  - generalized – F40.11
- functioning in childhood – F94.9
  - specified NEC – F94.8
- pragmatic – F80.82
soft tissue – M79.9
- ankle – M79.9
- due to use, overuse and pressure – M70.90
  - ankle – M70.97- (header)
  - bursitis – see Bursitis
  - foot – M70.97- (header)
  - forearm – M70.93- (header)
  - hand – M70.94- (header)
  - lower leg – M70.96- (header)
  - multiple sites – M70.99
  - pelvic region – M70.95- (header)
  - shoulder region – M70.91- (header)
  - specified site NEC – M70.98
  - specified type NEC – M70.80
    - ankle – M70.87- (header)
    - foot – M70.87- (header)
    - forearm – M70.83- (header)
    - hand – M70.84- (header)
    - lower leg – M70.86- (header)
    - multiple sites – M70.89
    - pelvic region – M70.85- (header)
    - shoulder region – M70.81- (header)
    - specified site NEC – M70.88
    - thigh – M70.85- (header)
    - upper arm – M70.82- (header)
  - thigh – M70.95- (header)
  - upper arm – M70.92- (header)
- foot – M79.9
- forearm – M79.9
- hand – M79.9
- lower leg – M79.9
- multiple sites – M79.9
- occupational – see Disorder, soft tissue, due to use, overuse and pressure
- pelvic region – M79.9
- shoulder region – M79.9
- specified type NEC – M79.89
- thigh – M79.9
- upper arm – M79.9
somatic symptom – F45.1
somatization – F45.0
somatoform – F45.9
- pain (persistent) – F45.41
- somatization (multiple) (long-lasting) – F45.0
- specified NEC – F45.8
- undifferentiated – F45.1
somnolence, excessive – see Hypersomnia
specific
- arithmetical – F81.2
- developmental, of motor – F82
- reading – F81.0
- speech and language – F80.9
- spelling – F81.81
- written expression – F81.81
speech – R47.9
- articulation (functional) (specific) – F80.0
- developmental – F80.9
- specified NEC – R47.89
speech-sound – F80.0
spelling (specific) – F81.81
spine – see also Dorsopathy
- ligamentous or muscular attachments, peripheral – see Enthesopathy, spinal
- specified NEC – see Dorsopathy, specified NEC
stereotyped, habit or movement – F98.4
stimulant use (other) (unspecified)
- mild – F15.10
  - in remission (early) (sustained) – F15.11
- moderate or severe – F15.20
  - in remission (early) (sustained) – F15.21
stomach (functional) – see Disorder, gastric
stress – F43.9
- acute – F43.0
- post-traumatic – F43.10
  - acute – F43.11
  - chronic – F43.12
substance use (other) (unknown)
- mild – F19.10
  - with substance-induced
    - anxiety disorder – F19.180
    - bipolar and related disorder – F19.14
    - depressive disorder – F19.14
    - major neurocognitive disorder – F19.17
    - mild neurocognitive disorder – F19.188
    - obsessive-compulsive and related disorder – F19.188
    - sexual dysfunction – F19.181
  - substance intoxication – F19.129
  - substance intoxication delirium – F19.121
- moderate or severe – F19.20
  - with substance-induced
    - anxiety disorder – F19.280
    - bipolar and related disorder – F19.24
    - depressive disorder – F19.24
    - major neurocognitive disorder – F19.27
    - mild neurocognitive disorder – F19.288
    - obsessive-compulsive and related disorder – F19.288
    - sexual dysfunction – F19.281
  - in remission (early) (sustained) – F19.21
  - substance intoxication – F19.229
  - substance intoxication delirium – F19.221
sulfur-bearing amino-acid metabolism – E72.10
sweat gland (eccrine) – L74.9
- apocrine – L75.9
  - specified NEC – L75.8
- specified NEC – L74.8
synovium – M67.90
- acromioclavicular – M67.91- (header)
- ankle – M67.97- (header)
- elbow – M67.92- (header)
- foot – M67.97- (header)
- forearm – M67.93- (header)
- hand – M67.94- (header)
- hip – M67.95- (header)
- knee – M67.96- (header)
- multiple sites – M67.99
- rupture – see Rupture, synovium
- shoulder – M67.91- (header)
- specified type NEC – M67.80
  - acromioclavicular – M67.81- (header)
  - ankle – M67.87- (header)
  - elbow – M67.82- (header)
  - foot – M67.87- (header)
  - hand – M67.84- (header)
  - hip – M67.85- (header)
  - knee – M67.86- (header)
  - multiple sites – M67.89
  - wrist – M67.83- (header)
- synovitis – see Synovitis
- upper arm – M67.92- (header)
- wrist – M67.93- (header)
temperature regulation, newborn – P81.9
- specified NEC – P81.8
temporomandibular joint – M26.60- (header)
tendon – M67.90
- acromioclavicular – M67.91- (header)
- ankle – M67.97- (header)
- contracture – see Contracture, tendon
- elbow – M67.92- (header)
- foot – M67.97- (header)
- forearm – M67.93- (header)
- hand – M67.94- (header)
- hip – M67.95- (header)
- knee – M67.96- (header)
- multiple sites – M67.99
- rupture – see Rupture, tendon
- shoulder – M67.91- (header)
- specified type NEC – M67.80
  - acromioclavicular – M67.81- (header)
  - ankle – M67.87- (header)
  - elbow – M67.82- (header)
  - foot – M67.87- (header)
  - hand – M67.84- (header)
  - hip – M67.85- (header)
  - knee – M67.86- (header)
  - multiple sites – M67.89
  - trunk – M67.88
  - wrist – M67.83- (header)
- synovitis – see Synovitis
- tendinitis – see Tendinitis
- tenosynovitis – see Tenosynovitis
- trunk – M67.98
- upper arm – M67.92- (header)
- wrist – M67.93- (header)
thoracic root (nerve) – G54.3
thyrocalcitonin hypersecretion – E07.0
thyroid (gland) – E07.9
- function NEC, neonatal, transitory – P72.2
- iodine-deficiency related – E01.8
- specified NEC – E07.89
tic – see Tic
tobacco use
- chewing tobacco (mild) (moderate) (severe)
  - in remission (early) (sustained) – F17.221
- cigarettes (mild) (moderate) (severe)
  - in remission (early) (sustained) – F17.211
- mild – F17.200
  - in remission (early) (sustained) – F17.201
- moderate – F17.200
  - in remission (early) (sustained) – F17.201
- severe – F17.200
  - in remission (early) (sustained) – F17.201
- specified product NEC (mild) (moderate) (severe)
  - in remission (early) (sustained) – F17.291
tooth – K08.9
- development – K00.9
  - specified NEC – K00.8
- eruption – K00.6
Tourette's – F95.2
trance and possession – F44.89
transvestic – F65.1
trauma and stressor-related NOS – F43.9
- other specified – F43.89
- unspecified – F43.9
tricuspid (valve) – see Endocarditis, tricuspid
tryptophan metabolism – E70.5
tubular, phosphate-losing – N25.0
tubulo-interstitial (in)
- brucellosis – A23.9 – N16 [manifestation]
- cystinosis – E72.04
- diphtheria – A36.84
- glycogen storage disease – E74.00 – N16 [manifestation]
- leukemia NEC – C95.9- (header) – N16 [manifestation]
- lymphoma NEC – C85.9- (header) – N16 [manifestation]
- mixed cryoglobulinemia – D89.1 – N16 [manifestation]
- multiple myeloma – C90.0- (header) – N16 [manifestation]
- Salmonella infection – A02.25
- sarcoidosis – D86.84
- sepsis – A41.9 – N16 [manifestation]
  - streptococcal – A40.9 – N16 [manifestation]
- systemic lupus erythematosus – M32.15
- toxoplasmosis – B58.83
- transplant rejection – T86.91 – N16 [manifestation]
- Wilson's disease – E83.01 – N16 [manifestation]
tubulo-renal function, impaired – N25.9
- specified NEC – N25.89
tympanic membrane – H73.9- (header)
- atrophy – see Atrophy, tympanic membrane
- infection – see Myringitis
- perforation – see Perforation, tympanum
- specified NEC – H73.89- (header)
unsocialized aggressive – F91.1
urea cycle metabolism – E72.20
- argininemia – E72.21
- arginosuccinic aciduria – E72.22
- citrullinemia – E72.23
- ornithine transcarbamylase deficiency – E72.4
- other specified – E72.29
ureter (in) – N28.9
- schistosomiasis – B65.0 – N29 [manifestation]
- tuberculosis – A18.11
urethra – N36.9
- specified NEC – N36.8
urinary system – N39.9
- specified NEC – N39.8
valve, heart
- aortic – see Endocarditis, aortic
- mitral – see Endocarditis, mitral
- pulmonary – see Endocarditis, pulmonary
- rheumatic
  - aortic – see Endocarditis, aortic, rheumatic
  - mitral – see Endocarditis, mitral
  - pulmonary – see Endocarditis, pulmonary, rheumatic
  - tricuspid – see Endocarditis, tricuspid
- tricuspid – see Endocarditis, tricuspid
vestibular function – H81.9- (header)
- specified NEC
  - in diseases classified elsewhere – H82.- (header)
- vertigo – see Vertigo
vision, binocular – H53.30
- abnormal retinal correspondence – H53.31
- diplopia – H53.2
- fusion with defective stereopsis – H53.32
- simultaneous perception – H53.33
- suppression – H53.34
visual
- cortex
  - blindness – H47.619
    - left brain – H47.612
    - right brain – H47.611
  - due to
    - inflammatory disorder – H47.629
      - left brain – H47.622
      - right brain – H47.621
    - neoplasm – H47.639
      - left brain – H47.632
      - right brain – H47.631
    - vascular disorder – H47.649
      - left brain – H47.642
      - right brain – H47.641
- pathway – H47.9
  - due to
    - inflammatory disorder – H47.51- (header)
    - neoplasm – H47.52- (header)
    - vascular disorder – H47.53- (header)
  - optic chiasm – see Disorder, optic, chiasm
vitreous body – H43.9
- crystalline deposits – see Deposit, crystalline
- degeneration – see Degeneration, vitreous
- hemorrhage – see Hemorrhage, vitreous
- opacities – see Opacity, vitreous
- prolapse – see Prolapse, vitreous
- specified type NEC – H43.89
voice – R49.9
- specified type NEC – R49.8
volatile solvent use
- due to drug abuse – see Abuse, drug, inhalant
- due to drug dependence – see Dependence, drug, inhalant
voyeuristic – F65.3
white blood cells – D72.9
- specified NEC – D72.89
withdrawing, child or adolescent – F40.10

How to choose the right code

Start with the main term, then pick the indented subterm that matches the documentation (type, cause, site, laterality, episode of care). Always confirm the code in the tabular list: follow its Excludes1/Excludes2, “code first” and “use additional code” notes, and add a 7th character where required.

Source: CDC/NCHS ICD-10-CM FY2027 alphabetic index.